
- /
- Supported exchanges
- / MU
- / B6E.MU
SWE ORPHAN BIOVITRU (B6E MU) stock market data APIs
SWE ORPHAN BIOVITRU Financial Data Overview
There is no Profile data available for B6E.MU.
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Or get access to advanced financial data starting only $19.99
Get SWE ORPHAN BIOVITRU data using free add-ons & libraries
Get SWE ORPHAN BIOVITRU Fundamental Data
SWE ORPHAN BIOVITRU Fundamental data includes:
- Net Revenue:
- EBITDA:
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
End-of-day & Earnings data
What’s included:
- Latest Release: 2025-10-23
- EPS/Forecast: 5.16
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
SWE ORPHAN BIOVITRU News

Sobi announces revised full year outlook and advances publication of the Q3 2025 financial report
STOCKHOLM, Oct. 19, 2025 /PRNewswire/ -- Swedish Orphan Biovitrum AB (publ) (Sobi®) (STO:SOBI) announces today a revised full year outlook for 2025 in response to recent developments. As a result o...


Swedish Orphan Biovitrum (OM:SOBI): Assessing Valuation After Recent Share Price Recovery
Swedish Orphan Biovitrum (OM:SOBI) shares have moved in recent trading, sparking investor curiosity about what may be driving the stock’s direction. The company has shown some ups and downs over the...

Invitation: Sobi's Q3 2025 report
STOCKHOLM, Oct. 8, 2025 /PRNewswire/ -- Sobi plans to publish its report for the third quarter of 2025 on 23 October 2025 at 08:00 CEST. Investors, analysts, and the media are invited to a conference...

Sobi Selects Kinaxis to Accelerate Access to Life-Changing Treatments
AI-powered supply chain orchestration and rare-disease innovation join forces for faster delivery of critical therapies to patients in need OTTAWA, Ontario, October 02, 2025--(BUSINESS WIRE)--Kinaxis...
Or get access to advanced financial data starting only $19.99
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.